Overview

While some progress had been made in terms of treatment access, substance use disorders increased in prevalence during the COVID-19 pandemic, with a resultant widening of the addiction treatment gap and a rise in overdose deaths.  In the face of this ongoing crisis, the ACGME mandated the inclusion of addiction medicine (AM) training during residency, while in 2023, the Consolidated Appropriations Act mandated eight hours of AM curricular exposure for all would-be controlled substance prescribers. Yet many residency programs still lack the expertise to deliver on these requirements.  Our workshop will focus on strategies to incorporate AM curricular experiences into primary care residency training, with a focus on experiential activities, including the logistical aspects of starting office-based opioid treatment (OBOT) within a resident clinic.  We will compare the experience of three different resident clinics, from academic and community-based programs, in different stages of development. Topics covered will include staffing, reimbursement, pharmacy regulations, clinic flow, and general operations.  During the workshop, participants will reflect upon the rationale for expanding AM training at their institution.  As participants may be in various stages of incorporating OBOT into resident training, we expect a rich discussion of challenges programs have faced and continue to faces). Participants will be invited to join a mentorship network that they may use going forward, as they begin to implement changes at their home institution.

Speakers

Stephen Holt, MD, MS
Anthony Aspesi, MD
Rachael  Truchil, MD
Olivia  Ramey, MD

Content Track

Curriculum 

Audience

GME

Program Type

University-Based, Community-Based

Additional Information

Year Published: 2024 - APDIM Fall Meeting 2024